| Literature DB >> 29229603 |
Chunliang Shang1, Wei Wang1, Yuandong Liao1, Yili Chen1, Tianyu Liu1, Qiqiao Du1, Jiaming Huang1, Yanchun Liang1, Junxiu Liu1, Yunhe Zhao1, Luyan Guo1, Zheng Hu2, Shuzhong Yao2.
Abstract
Cancer spread to lymph nodes predicts poor survival but underlying mechanisms remain little understood. In this study, we show that overexpression of the long noncoding RNA LNMICC associates with lymph node metastasis of primary cervical cancer, where it serves as an independent high-risk factor in patient survival. Functional investigations demonstrated that LNMICC promoted lymph node metastasis by reprogramming fatty acid metabolism, by recruiting the nuclear factor NPM1 to the promoter of the fatty acid binding protein FABP5. We also found that the prometastatic effects of LNMICC were directly targeted and suppressed by miR-190. Our results establish a new mechanism of lymph node metastasis and highlight LNMICC as a candidate prognostic biomarker and therapeutic target in cervical cancer.Significance: These results establish the role of a novel long noncoding RNA in lymph node metastasis, with implications as a candidate prognostic biomarker and therapeutic target in cervical cancer. Cancer Res; 78(4); 877-90. ©2017 AACR. ©2017 American Association for Cancer Research.Entities:
Mesh:
Substances:
Year: 2017 PMID: 29229603 DOI: 10.1158/0008-5472.CAN-17-2356
Source DB: PubMed Journal: Cancer Res ISSN: 0008-5472 Impact factor: 12.701